RxDoctor Payments Data

Mark Parrella, MD

Orthopaedic Trauma · Austin, TXNPI 1093851123

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (47.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Osteocentric Technologies, Inc. at 52.3% of the total.

$21,316in general payments, 2019–2025

Across 164 payments — averaging $129.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Osteocentric Technologies, Inc.$11K
  • Smith+Nephew$5K
  • Abbott$2K
  • Johnson & Johnson$2K
  • Sanara Medtech Inc.$599
  • Stryker$171
  • plus $1K from 18 others
$1,100,730in ownership & investment interests, 2019–2025

Across 7 payments — averaging $157,247 each. An ownership or investment interest held by the physician or an immediate family member.

  • Osteocentric Technologies, Inc.$1.1M

What the payments were for

  • Consulting fees$6,00028%
  • Travel & lodging$5,28125%
  • Food & beverage$10,03547%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,316 in reported general payments places this provider in the 55th percentile of 74 orthopaedic trauma providers in Texas.

See all orthopaedic trauma providers in Texas

Medicare billing

Part B allowed, 2024
$318,618
Medicare patients
297
Services billed
1,326

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen83$902
Methocarbamol13$82
Tramadol Hcl13$61

Paid to pharmacies, not to this prescriber.

Other orthopaedic trauma in Austin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →